Resistance to antiplatelet drugs in patients with cardiovascular diseases and diabetes
Journal Title: Postępy Nauk Medycznych - Year 2013, Vol 26, Issue 3
Abstract
Treatment with antiplatelet drugs – aspirin (ASA) and clopidogrel – is a standard procedure in patients with cardiovascular disease, especially after ACS and invasive treatment. Despite this, cardiac events, including premature restenosis, occur in a number of patients. Such complications are partially ascribed to resistance to aspirin and/or clopidogrel. This phenomenon results in high on treatment platelet reactivity (HTPR) which seems to be more pronounced in patients with diabetes. There are several mechanism which may play a role in diabetic patients such as glycation of platelet proteins, increased platelet turnover, insulin resistance, oxidative stress, reduced bioavailability of the drugs or their metabolites. The frequency of cardiac events is associated with laboratory determined HTPR and cannot be significantly reduced by increasing doses of aspirin and clopidogrel. The way to overcome resistance to the above medicines is to use new antiplatelet drugs. Prasugrel and ticagrelor proved to be more effective than clopidogrel in reducing cardiac events in patients treated with PCI. These drugs are approved by ESC and AHA for treatment of ACS patients (with few exceptions e.g. excessive risk of major bleeding). Prasugrel appears to be especially effective in patients with diabetes. Triple antiplatelet therapy (with cilostazol added to ASA and clopidogrel) seems to offer some additional benefit in patients with diabetes but results of available studies are equivocal.
Authors and Affiliations
Wiesław Piechota
Keywords
Related Articles
- EP ID EP54687
- DOI -
- Views 124
- Downloads 0
Imaging in Graves’ orbitopathy
Diagnosis of Graves orbitopathy is based on the typical eye signs and symptoms, the evidence of thyroid autoimmunity and exclusion of other orbital pathologies. Orbital imaging helps to support the clinical diagnosis of...
Thyronamines – decarboxylated derivatives of thyroid hormones – new family of endogenous signaling molecules?
Thyronamines (TAMs) are derivatives of thyroid hormones, produced via decarboxylation of the alanine chain. They act as endogenous signaling molecules and were firstly discovered in early 50thies of the XXth century. The...
Typical and atypical symptoms of cardiac arrhythmias
Arrhythmic symptoms are the most important predictors of quality of life and cost-effectiveness of its treatment. Moreover, symptoms are the key point of non-invasive and invasive antiarrhythmic treatment for the managem...
Endovascular treatment of carotid cavernous fistulas
Carotid caveronus fistulas are incorrect connections between carotid arteries and cavernous sinus. Presence of such fistulas results with elevated blood pressure in caveronus sinus and draining vessels. Development of en...
If the Helicobacter pylori infection may affect ghrelin secretion in children
<b>Introduction. </b><i>Helicobacter pylori</i> is considered as an etiologic agent of the gastric mucosa diseases. Therefore, it may affect ghrelin secretion, know...